Ball of progenitor cells injected into the eye

UCI-led team begins first clinical trial of stem cell-based retinitis pigmentosa treatment

Participants are being enrolled in the first clinical trial that tests the use of retinal progenitor cells to treat retinitis pigmentosa. The product of stem cell research at UCI’s Gavin Herbert Eye Institute and Sue & Bill Gross Stem Cell Research Center, these retinal progenitors are similar to stem cells in terms of potential regenerative

READ MORE…

Indirect laser treatment

Belize July 2015

This trip was supported by Allergan Foundation, with instrument support from IRIDEX. Our CEO Dr Raj Agrawal made his second trip to Belize recently. This time, apart from seeing patients in Belize City, he also traveled to Orange Walk, which is an hour’s drive away from Belize City, as well as to Dangriga, which is

READ MORE…

Bahamas May 2015

To read more about the Bahamas, and why our help is required in the country, click here. As part of our outreach medical visits, Suber Huang, MD, and Raj Agrawal, MD, visited Nassau, Bahamas, in May 2015. This visit was in collaboration with the Rotary Club of East Nassau, who also sponsored our visit, as

READ MORE…

Visit to Belize

This project has been made possible by a grant from Allergan Foundation. Driving to BCVI’s National Eye Clinic BCVI’s National Eye Clinic BCVI’s National Eye Clinic Belize City Pouring rain in Belize City An ROP baby being examined in the clinic Discussing the outcomes of the exam with the mother Discussing the outcomes of the

READ MORE…

Is Avastin better than Lucentis for AMD?

A group of researchers from China have evaluated randomized controlled clinical trials from around the world to study the efficacy and safety of Avastintm (bevacizumab) versus Lucentistm (ranibizumab) in wet (neovascular) age-related macular degeneration (AMD).

Telemedicine of ROP babies makes for early diagnosis and treatment

Retinopathy of prematurity (ROP) continues to be an ongoing challenge for both ophthalmologists and neonatologists and remains a significant threat to vision for extremely premature infants despite the availability of therapeutic modalities. It remains a leading cause of morbidity despite, (and interestingly) as well as because of, advances in neonatal care, which have improved survival

READ MORE…

AMD may be triggered by tiny mineral deposits in retina

Scientists from the University of Maryland School of Medicine have found that tiny lumps of calcium phosphate may be an important triggering factor for age-related macular degeneration (AMD). This is the first time these mineral deposits have been implicated in the disease, which affects more than 10 million Americans.